Clinical Trials Logo

Filter by:
NCT ID: NCT05029479 Active, not recruiting - Geriatric Patients Clinical Trials

the Clinical Performance of a Moisture Resistant, M-TEG-P Phosphate Monomer Based Universal Adhesive (YAMAKIN TMR-Aquabond0) Compared to the Conventional Universal Adhesive (3m ESPE Single Bond Universal Adhesive)

Start date: October 13, 2021
Phase: N/A
Study type: Interventional

this trial is to test the clinical performance of a novel moisture resistant, M-TEG-P phosphate monomer based universal adhesive (YAMAKIN TMR-Aquabond0) compared to the conventional universal adhesive (3m ESPE Single Bond Universal Adhesive) in geriatric patients with Non-carious Cervical lesions (NCLLs)

NCT ID: NCT05023395 Active, not recruiting - Clinical trials for Urinary Tract Infections

Safety and Efficacy of MEE-HU Medicus

(SEM)
Start date: October 23, 2021
Phase: Phase 2
Study type: Interventional

Primary objective: is evaluation of the investigational product's safety and evaluation of its effect, in combination with antimicrobial treatment, on urine culture (microbiological cure, no microbial growth on 24-48 hrs culture). The secondary objective: is evaluation of the investigational product's effect, in combination with antimicrobial treatment, on disease related symptoms (Clinical cure, disappearance of symptoms and signs).

NCT ID: NCT05020431 Active, not recruiting - Clinical trials for Collagen Degeneration

Type I Collagen Fragments in the GCF and Saliva During OTM

Start date: May 15, 2021
Phase: N/A
Study type: Interventional

Investigate the levels of type I Collagen fragments ICTP and CTX in GCF and saliva during initial leveling and alignment of the teeth in a sample of adolescents undergoing orthodontic treatment.

NCT ID: NCT05005767 Active, not recruiting - Clinical trials for Chronic Periodontitis

Effect of Frankincense Extract Gel on Non-Surgical Treatment of Chronic Periodontitis

Start date: April 1, 2021
Phase: Phase 2
Study type: Interventional

This study will evaluate the effect of the subgingival application of Frankincense extract gel as an adjunct to scaling and root planning (SRP) in chronic periodontitis.

NCT ID: NCT05003258 Active, not recruiting - Macular Edema Clinical Trials

Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients With Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection

Start date: October 7, 2021
Phase: N/A
Study type: Interventional

Retinal vein occlusion (RVO) is one of the most common causes of vision loss due to retinal vascular disease. Incidence of RVO has been raised in the last years due to increased coexisting systemic vascular risk factors as arterial hypertension, obesity, diabetes mellitus and COVID-19. Macular edema (ME) is a major sight-threatening complication of branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). BRVO and CRVO have the same pathology, an elevation in the intravascular pressure in the occluded vein leading to vascular wall damage causing leakage of fluid and release of inflammatory cytokines as vascular endothelial growth factor (VEGF), respectively. In the past, the standard treatment for BRVO-related ME was grid laser photocoagulation and for CRVO-related ME was observation. But subsequent randomized controlled trials demonstrated significant functional and anatomical improvements among patients with ME secondary to BRVO or CRVO treated with intravitreal injections of vascular endothelial growth factor (VEGF) inhibitors or corticosteroids compared to those treated with laser only. Anti-VEGF therapy decrease intravenous pressure, enhance blood flow and improve venous diameter and tortuosity. Also, intravitreal corticosteroid injection has been shown to improve vision and central macular thickness (CMT). Dexamethasone intravitreal implant (Ozurdex®, Allergan Inc., Irvine, CA, USA) has potent antiangiogenic and anti-inflammatory effects. Also it decreases the vascular permeability playing an important role in treating ME secondary to RVO. However, majority of eyes have been treated previously then shifted to dexamethasone implant as a second line for treatment of refractory RVO related ME.

NCT ID: NCT04998214 Active, not recruiting - COVID-19 Clinical Trials

Hepatic Manifestations and Effect of Long COVID-19 on Patients With Chronic Liver Disease

Start date: August 19, 2021
Phase:
Study type: Observational

To measure the frequency of persistent liver dysfunction (raised liver enzymes, serum albumin, prothrombin time, etc) in recovered COVID -19 patients. To compare the hepatic manifestations in post COVID -19 patients with and without liver disease

NCT ID: NCT04981457 Active, not recruiting - Missed Abortion Clinical Trials

Comparative Study Between Combined Vaginal Misoprostol

comparative
Start date: March 2, 2021
Phase: Phase 1
Study type: Interventional

"Comparative study between Combined Vaginal Misoprostol with Isosorbide-5-Mononitrate

NCT ID: NCT04981353 Active, not recruiting - Clinical trials for Numerical Rating Pain Score

Thoracic Erector Spinae Plane Block for Painless 1st Stage Normal Vaginal Delivery: Randomized Controlled Study

Start date: July 5, 2021
Phase: N/A
Study type: Interventional

this study will test a novel indication for bilateral erector spinae plane block (painless 1st stage normal vaginal delivery) it depends on the hypnosis that the erector spinae plane block blocks the visceral pain also by affecting the ventral rami, dorsal rami and rami communicants.

NCT ID: NCT04967040 Active, not recruiting - Foot Injury Clinical Trials

Reconstruction of Ankle and Foot Defects

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Reconstruction of soft tissue defects around the foot and ankle region is a challenging problem for reconstructive surgeons due to the lack of locally available tissues for transposition, the relatively poor skin circulation, and the special structural characteristics of this area, bones and tendons can easily become exposed due to trauma. so foot injuries are often associated with a loss of soft tissues and exposed bones . The plantar skin is thick, with solid anchorage to the deep structures. Therefore, the reconstructive aim is to restore the stability of the foot skin to adapt to weightbearing and to resist shearing forces. In addition, good sensibility should be considered in the reconstruction. Additional considerations the ankle region has great tension during movement, and good stability is required for shoes wearing. The medial plantar flap has been effectively used in the reconstruction of soft tissue defects localized to the plantar foot, forefoot, posterior heel, and ankle in small to medium sized defects . This flap can be transferred to the defect as a proximally or distally pedicled island flap . The distally based sural artery flap frequently used for reconstruction of soft tissue defects of the lower leg, foot and ankle in medium and large sized defects .Fascio-cutaneous flaps are highly effective and easy to perform. This study is a comparative study designed for assessment of the clinical applications of distally based sural flap versus medial plantar artery flap regarding the size of the defect , operative technique and their outcomes (success and complications) as a reconstructive option for foot and ankle defects.

NCT ID: NCT04966078 Active, not recruiting - Gynecomastia Clinical Trials

Treatment of Mild and Moderate Cases of Gynaecomastia

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

This study aims to compare liposuction and periareolar surgical excision in mild and moderate cases of gynecomastia as regard cosmosis, complications, patient satisfaction, operation time, and hospital stay. This study will be carried out on patients with gynecomastia presented to the Plastic Surgery Department, Sohag University, in the period between January 2021 to January 2022 as a retrospective and prospective study. Patients will be divided into 2 groups: group A treated with suction-assisted liposuction. group B treated with peri-areolar surgical excision. Each group contains 20 patients.